ICA-121431
CAS No. 313254-51-2
ICA-121431( 22-Diphenyl-N-[4-(thiazol-2-ylsulfamoyl )
Catalog No. M20736 CAS No. 313254-51-2
ICA-121431 is a nanomolar potent small molecule Nav1.7 channel inhibitor with IC50 of 19 nM for rat Nav1.7 with little or no activity against human Nav1.5 or Nav1.7 channels.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 65 | In Stock |
|
| 2MG | 38 | In Stock |
|
| 5MG | 61 | In Stock |
|
| 10MG | 86 | In Stock |
|
| 25MG | 150 | In Stock |
|
| 50MG | 246 | In Stock |
|
| 100MG | 370 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameICA-121431
-
NoteResearch use only, not for human use.
-
Brief DescriptionICA-121431 is a nanomolar potent small molecule Nav1.7 channel inhibitor with IC50 of 19 nM for rat Nav1.7 with little or no activity against human Nav1.5 or Nav1.7 channels.
-
DescriptionICA-121431 is a nanomolar potent small molecule Nav1.7 channel inhibitor with IC50 of 19 nM for rat Nav1.7 with little or no activity against human Nav1.5 or Nav1.7 channels.
-
In VitroICA-121431 interacts with human Nav1.3 and the amino acid residues that may define selectivity for this channel over other related Nav?channels, including Nav1.7 and Nav 1.5. Data generated using conventional patch clamp electrophysiological recording using a pulse protocol whereby a 20-ms test pulse is preceded by an 8-s step to a voltage that inactivated half of the channels.ICA-121431 is against Wild type hNav1.3 hNav1.5 hNav1.7 with IC50s of 0.013 μM, >30 μM, 12 μM, respectively.ICA-121431 is againsthNav channels with point mutations,shows hNav1.3 M1 (S1510Y), hNav1.3 M2 (R1511W), hNav1.3 M3 (E1559D), hNav1.3 M1,3 (S1510Y/E1559D), hNav1.3 M2, 3 (R1511W/E1559D), hNav1.3 M1, 2, 3 (S1510Y/R1511W/E1559D), and hNav1.7 M1, 2, 3 (Y1537S/W1538R/D1586E) with IC50 values of 0.1 μM, 0.37 μM, 1.1 μM, 1.3 μM, 1.9 μM, 11.6 μM, 0.032 μM, respectively.ICA-121431 is againsthNav channels with point mutations,shows hNav1.3/hNav1.5 S1-S4, hNav1.3/hNav1.5 S3-S4, hNav1.3/hNav1.5 S5-S6, hNav1.3/hNav1.7 S1, hNav1.3/hNav1.7 S2, hNav1.3/hNav1.7 S3-S4, and hNav1.3/hNav1.7 S5-S6 with IC50 values of 0.083 μM, 1.2 μM, 11 μM, 2.0 μM, 0.045 μM, 0.030 μM, 0.30 μM, 1.0 μM, and 0.024 μM, respectively.
-
In Vivo——
-
Synonyms22-Diphenyl-N-[4-(thiazol-2-ylsulfamoyl
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorNav1.7 channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number313254-51-2
-
Formula Weight449.55
-
Molecular FormulaC23H19N3O3S2
-
Purity>98% (HPLC)
-
SolubilityDMSO:44 mg/mL (97.88 mM)
-
SMILESO=C(Nc1ccc(cc1)S(=O)(=O)Nc1nccs1)C(c1ccccc1)c1ccccc1
-
Chemical Name22-diphenyl-N-(4-(N-(thiazol-2-yl)sulfamoyl)phenyl)acetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Song G Yang D Wang Y et al. Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators[J]. Nature 2017.
molnova catalog
related products
-
Trapencaine
Trapencaine is a newly synthesized carbamate type local anesthetic that induces conformational changes in sodium channels on hypertrophic cell membranes.
-
PF-06869206
PF-06869206 is an oral selective inhibitor of the sodium-phosphate cotransporter NaPi2a (SLC34A1, IC50: 380 nM).
-
PF-05089771
PF-05089771 is a potent, state-dependent, subtype selective Nav1.7 inhibitor with IC50 of 11 nM.
Cart
sales@molnova.com